{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T02:08:43Z","timestamp":1775354923336,"version":"3.50.1"},"reference-count":29,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2021]]},"DOI":"10.1620\/tjem.253.19","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T22:15:37Z","timestamp":1610489737000},"page":"19-28","source":"Crossref","is-referenced-by-count":11,"title":["JNK Pathway-Associated Phosphatase as a Serum Marker for Disease Activity and Treatment Outcome of Juvenile Idiopathic Arthritis"],"prefix":"10.1620","volume":"253","author":[{"given":"Songbai","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pediatrics Nephrology, Maternal and Child Health Hospital of Hubei Province"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Nephrology, Maternal and Child Health Hospital of Hubei Province"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangman","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alexeeva, E.I., Namazova-Baranova, L.S., Bzarova, T.M., Valieva, S.I., Denisova, R.V., Sleptsova, T.V., Isaeva, K.B., Chomahidze, A.M., Taibulatov, N.I., Fetisova, A.N., Karaseva, A.V. & Baranov, A.A. (2017) Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children\u2019s Health, Russia. Pediatr. Rheumatol. Online J.<\/i>, 15, 51.","DOI":"10.1186\/s12969-017-0178-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Alonso, A., Merlo, J.J., Na, S., Kholod, N., Jaroszewski, L., Kharitonenkov, A., Williams, S., Godzik, A., Posada, J.D. & Mustelin, T. (2002) Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR). J. Biol. Chem.<\/i>, 277, 5524-5528.","DOI":"10.1074\/jbc.M107653200"},{"key":"3","unstructured":"Chen, A.J., Zhou, G., Juan, T., Colicos, S.M., Cannon, J.P., Cabriera-Hansen, M., Meyer, C.F., Jurecic, R., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Fletcher, F., Tan, T.H. & Belmont, J.W. (2002) The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway. J. Biol. Chem.<\/i>, 277, 36592-36601."},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chuang, H.C., Chen, Y.M., Hung, W.T., Li, J.P., Chen, D.Y., Lan, J.L. & Tan, T.H. (2016) Downregulation of the phosphatase JKAP\/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis. Oncotarget<\/i>, 7, 57593-57605.","DOI":"10.18632\/oncotarget.11419"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chuang, H.C. & Tan, T.H. (2019) MAP4K family kinases and DUSP family phosphatases in T-cell signaling and systemic lupus erythematosus. Cells<\/i>, 8, 1433.","DOI":"10.3390\/cells8111433"},{"key":"6","unstructured":"Consolaro, A., Ruperto, N., Bazso, A., Pistorio, A., Magni-Manzoni, S., Filocamo, G., Malattia, C., Viola, S., Martini, A. & Ravelli, A.; Paediatric Rheumatology International Trials Organisation (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum.<\/i>, 61, 658-666."},{"key":"7","unstructured":"Crayne, C.B. & Beukelman, T. (2018) Juvenile idiopathic arthritis: oligoarthritis and polyarthritis. Pediatr. Clin. North Am.<\/i>, 65, 657-674."},{"key":"8","unstructured":"Giancane, G., Consolaro, A., Lanni, S., Dav\u00ec, S., Schiappapietra, B. & Ravelli, A. (2016) Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol. Ther.<\/i>, 3, 187-207."},{"key":"9","unstructured":"Jeffrey, K.L., Camps, M., Rommel, C. & Mackay, C.R. (2007) Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat. Rev. Drug Discov.<\/i>, 6, 391-403."},{"key":"10","unstructured":"Kasap\u00e7opur, \u00d6. & Barut, K. (2015) Treatment in juvenile rheumatoid arthritis and new treatment options. Turk Pediatri Ars.<\/i>, 50, 1-10."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kearsley-Fleet, L., Davies, R., Lunt, M., Southwood, T.R. & Hyrich, K.L. (2016) Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Rheumatology <\/i>(Oxford<\/i>), 55, 840-847.","DOI":"10.1093\/rheumatology\/kev434"},{"key":"12","unstructured":"Khraishi, M., Millson, B., Woolcott, J., Jones, H., Marshall, L. & Ruperto, N. (2019) Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J.<\/i>, 17, 64."},{"key":"13","unstructured":"Lee, J.J.Y. & Schneider, R. (2018) Systemic juvenile idiopathic arthritis. Pediatr. Clin. North Am.<\/i>, 65, 691-709."},{"key":"14","unstructured":"Li, J.P., Fu, Y.N., Chen, Y.R. & Tan, T.H. (2010) JNK pathway-associated phosphatase dephosphorylates focal adhesion kinase and suppresses cell migration. J. Biol. Chem.<\/i>, 285, 5472-5478."},{"key":"15","unstructured":"Li, J.P., Yang, C.Y., Chuang, H.C., Lan, J.L., Chen, D.Y., Chen, Y.M., Wang, X., Chen, A.J., Belmont, J.W. & Tan, T.H. (2014) The phosphatase JKAP\/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck. Nat. Commun.<\/i>, 5, 3618."},{"key":"16","doi-asserted-by":"crossref","unstructured":"M\u00e9lard, P., Idrissi, Y., Andrique, L., Poglio, S., Prochazkova-Carlotti, M., Berhouet, S., Boucher, C., Laharanne, E., Chevret, E., Pham-Ledard, A., De Souza G\u00f3es, A.C., Guyonnet-Duperat, V., Bibeyran, A., Moreau-Gaudry, F., Vergier, B., et al. (2016) Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes. Oncotarget<\/i>, 7, 68734-68748.","DOI":"10.18632\/oncotarget.11930"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Mori, M., Sugiyama, N., Morishima, Y., Sugiyama, N., Kokubo, T., Takei, S. & Yokota, S. (2018) Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: results from a postmarketing surveillance. Mod. Rheumatol.<\/i>, 28, 101-107.","DOI":"10.1080\/14397595.2017.1310704"},{"key":"18","unstructured":"Murdaca, G., Negrini, S., Magnani, O., Penza, E., Pellecchio, M., Gulli, R., Mandich, P. & Puppo, F. (2018) Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis. Mod. Rheumatol.<\/i>, 28, 417-431."},{"key":"19","unstructured":"Petty, R.E., Southwood, T.R., Manners, P., Baum, J., Glass, D.N., Goldenberg, J., He, X., Maldonado-Cocco, J., Orozco-Alcala, J., Prieur, A.M., Suarez-Almazor, M.E. & Woo, P.; International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol.<\/i>, 31, 390-392."},{"key":"20","doi-asserted-by":"crossref","unstructured":"Prakken, B., Albani, S. & Martini, A. (2011) Juvenile idiopathic arthritis. Lancet<\/i>, 377, 2138-2149.","DOI":"10.1016\/S0140-6736(11)60244-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Shepherd, J., Cooper, K., Harris, P., Picot, J. & Rose, M. (2016) The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation. Health Technol. Assess.<\/i>, 20, 1-222.","DOI":"10.3310\/hta20340"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Shi, X., Yang, W., Wang, N. & Zhu, J. (2019) Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-alpha inhibitor in Crohn disease patients. Medicine <\/i>(Baltimore<\/i>), 98, e16622.","DOI":"10.1097\/MD.0000000000016622"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Thierry, S., Fautrel, B., Lemelle, I. & Guillemin, F. (2014) Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine<\/i>, 81, 112-117.","DOI":"10.1016\/j.jbspin.2013.09.003"},{"key":"24","unstructured":"Twilt, M., Pradsgaard, D., Spannow, A.H., Horlyck, A., Heuck, C. & Herlin, T. (2017) Joint cartilage thickness and automated determination of bone age and bone health in juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J.<\/i>, 15, 63."},{"key":"25","unstructured":"Walters, H.M., Pan, N., Lehman, T.J., Adams, A., Kalliolias, G.D., Zhu, Y.S., Santiago, F., Nguyen, J., Sitaras, L., Cunningham-Rundles, S., Walsh, T.J. & Toussi, S.S. (2016) The impact of disease activity and tumour necrosis factor-alpha inhibitor therapy on cytokine levels in juvenile idiopathic arthritis. Clin. Exp. Immunol.<\/i>, 184, 308-317."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Zhang, B. & Jiang, W. (2019) IL-1beta, IL-17A, CRP and biologics history might serve as potential markers for clinical response to etanercept in rheumatoid arthritis patients. Inflammopharmacology<\/i>, 27, 1123-1130.","DOI":"10.1007\/s10787-019-00624-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Zhao, M. & Huang, X. (2019) Downregulation of JKAP is correlated with elevated disease risk, advanced disease severity, higher inflammation, and poor survival in sepsis. J. Clin. Lab. Anal.<\/i>, 33, e22945.","DOI":"10.1002\/jcla.22945"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Zhou, L. & Gu, X. (2019) Correlation of ultrasonography synovitis with disease activity and clinical response to etanercept treatment in juvenile idiopathic arthritis patients. Braz. J. Med. Biol. Res.<\/i>, 52, e8565.","DOI":"10.1590\/1414-431x20198565"},{"key":"29","unstructured":"Zhou, R., Chang, Y., Liu, J., Chen, M., Wang, H., Huang, M., Liu, S., Wang, X. & Zhao, Q. (2017) JNK pathway-associated phosphatase\/DUSP22 suppresses CD4+<\/sup> T-cell activation and Th1\/Th17-cell differentiation and negatively correlates with clinical activity in inflammatory bowel disease. Front. Immunol.<\/i>, 8, 781."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/253\/1\/253_19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T03:47:13Z","timestamp":1610768833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/253\/1\/253_19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.253.19","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}